TELUS Corp Stock (ISIN: CA87971M1032) Holds Steady Amid Telecom Sector Pressures as Q4 2025 Results Highlight Resilience

TELUS Corp stock (ISIN: CA87971M1032), the Canadian telecommunications giant, closed at 18.70 CAD on February 27, 2026, reflecting a slight daily dip of 0.11% but a year-to-date increase of 0.48%. This performance comes in the wake of the company's Q4 2025 earnings release on February 12, 2026, which highlighted steady revenue growth and reaffirmed commitment to shareholder returns through robust dividends. For English-speaking investors, particularly those in Europe and the DACH region tracking North American dividend payers, TELUS offers a compelling mix of defensive qualities and growth in health tech amid sector headwinds.

As of: 19.03.2026

By Eleanor Voss, Senior Telecom Equity Analyst - Specializing in North American dividend aristocrats and their appeal to European portfolios.

Current Market Snapshot for TELUS Corp Stock

The TELUS Corp stock (ISIN: CA87971M1032) has navigated a volatile start to 2026, with shares fluctuating between 18.44 CAD and 18.72 CAD over the last trading days of February. Trading volume remained healthy, averaging over 6 million shares daily, indicating sustained investor interest despite broader market rotations away from high-yield telecoms. Market capitalization stands at approximately 29.19 billion CAD, underscoring TELUS's position as one of Canada's largest integrated telecom providers.

From a technical standpoint, the stock exhibits resilience, supported by a forward P/E ratio of 25.5x for 2026 and an attractive dividend yield forecast of 8.95%, rising slightly to 8.68% in 2027. This yield profile positions TELUS favorably against peers, especially as inflation concerns linger in global markets. For DACH investors, who often prioritize income stability via Xetra-traded instruments or ETFs, TELUS's inclusion in vehicles like the State Street SPDR S&P Global Dividend Aristocrats ETF adds accessibility and diversification appeal.

Q4 2025 Earnings: Key Drivers and Market Reaction

TELUS reported its Q4 2025 results via an earnings call on February 12, 2026, with transcripts highlighting consistent performance across core segments: mobility, fixed broadband, and emerging digital health services. Revenue projections for 2026 are set at 21.02 billion CAD, up from prior periods, driven by postpaid mobile subscriber growth and fibre network expansions. Net income is forecasted at 1.12 billion CAD, reflecting operational efficiencies despite rising capital expenditures for 5G rollouts.

The market's muted response post-earnings suggests investors are pricing in regulatory risks and competitive pricing pressures from rivals like Rogers and Bell Canada. However, TELUS's net debt of 27.54 billion CAD remains manageable relative to enterprise value, supporting ongoing dividend hikes. Why does this matter now? With central banks signaling prolonged higher rates, TELUS's high yield serves as a buffer, particularly for yield-hungry European portfolios seeking alternatives to domestic utilities.

Business Model Breakdown: Telecom Core Meets Health Tech Innovation

TELUS operates as a holding company with TELUS Corporation (TSX: T) as the primary listed ordinary share entity under ISIN CA87971M1032. Its integrated model spans wireless services (45% of revenue), wireline broadband, and TELUS Health/International segments, providing diversification beyond pure telecom exposure. This structure differentiates TELUS from pure-play mobile operators, with health tech contributing high-margin recurring revenue from electronic health records and pharmacy management.

For 2026, EV/Revenue multiples of 2.7x indicate reasonable valuation given projected sales of 21.02 billion CAD. Operating leverage from scale in fibre-to-the-home (FTTH) deployments could drive margin expansion if subscriber ARPU stabilizes. European investors appreciate this hybrid model, akin to Deutsche Telekom's mix of telecom and tech services, offering growth offsets to cyclical wireless pressures.

DACH and European Investor Perspective

While primarily listed on the Toronto Stock Exchange, TELUS Corp stock (ISIN: CA87971M1032) garners attention in Europe through indices like Euronext's EN Developed World Total Market NR and EN World, where it features alongside peers such as Telia and Telstra. DACH portfolios, often benchmarked against MSCI World, benefit from TELUS's 1.55% weighting in the SPDR S&P Global Dividend Aristocrats ETF, providing CAD exposure hedged against euro weakness.

German and Swiss investors, facing subdued yields in domestic bonds, view TELUS as a stable income play. Its progression as a dividend aristocrat - with quarterly payouts totaling around 1.27 USD annually - aligns with conservative strategies. Xetra liquidity for related ETFs enhances accessibility without direct ADR complexities.

Segment Performance and Operating Environment

Mobility remains TELUS's cornerstone, with postpaid net adds supporting 2026 revenue forecasts. Fixed services face cord-cutting headwinds, but PureFibre expansions mitigate churn, targeting 30%+ penetration in key markets. TELUS Health, a bright spot, leverages AI-driven telehealth amid Canada's aging population, potentially accelerating to double-digit growth.

The Canadian telecom environment is intensely competitive post-Rogers-Shaw merger, with CRTC regulations capping price hikes. Input costs for spectrum auctions pressure capex, but TELUS's 99.77% free float ensures broad ownership alignment. End-market demand for 5G and IoT remains robust, driven by enterprise digitization.

Margins, Cash Flow, and Capital Allocation

Forecasted net income of 1.12 billion CAD for 2026 supports dividend sustainability, with yields projected above 8%. Free cash flow generation, post-capex, funds buybacks and debt reduction, targeting net debt-to-EBITDA below 3x. Balance sheet strength allows flexibility for M&A in health tech, balancing growth and returns.

Trade-offs include high capex intensity (fibre/5G), limiting near-term deleveraging. However, operating leverage from scale could lift EBITDA margins to 40%+ if ARPU recovers. For investors, this implies a patient hold strategy, prioritizing yield over capital appreciation.

Competition, Risks, and Catalysts

Competitors like BCE and Rogers challenge market share, but TELUS's western Canada stronghold and health diversification provide moats. Risks encompass regulatory price controls, spectrum costs, and macroeconomic slowdowns impacting consumer spending. Upside catalysts include TELUS Health acquisitions, 5G enterprise wins, and dividend increases.

Sector tailwinds from AI data demands favor incumbents with infrastructure. Sentiment remains neutral, with no major analyst downgrades post-earnings.

Valuation and Outlook

At 25.5x 2026 P/E, TELUS trades at a premium to historical averages but justifies it via growth and yield. European investors should monitor CAD/EUR rates, as currency strength could enhance returns. Overall, TELUS Corp stock offers defensive positioning with upside in tech adjacencies, meriting watchlists for DACH income strategies.

Disclaimer: Not investment advice. Stocks are volatile financial instruments.